Current approaches to targeting cancer using antiangiogenesis therapies.
Scott
P A
PA
Imperial Cancer Research Fund Laboratories, University of Oxford, John Radcliffe Hospital, U.K.
Harris
A L
AL
D000595:Amino Acid Sequence; D000818:Animals; D010450:Endopeptidases / Q000502:physiology; D005109:Extracellular Matrix / Q000502:physiology; D006131:Growth Inhibitors / Q000627:therapeutic use; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000098:blood supply* / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000503:physiopathology / Q000517:prevention & control; D011480:Protease Inhibitors / Q000627:therapeutic use
D006131:Growth Inhibitors; D006133:Growth Substances; D011480:Protease Inhibitors; D010450:Endopeptidases